Citation

Henriksson S, Boëthius G, Isacsson G. Acta Psychiatr. Scand. 2001; 103(4): 301-306.

Affiliation

NEUROTEC, Division of Psychiatry, Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden.

Copyright

(Copyright © 2001, John Wiley and Sons)

DOI

unavailable

PMID

11328245

Abstract

OBJECTIVE: This study presents data relating to prospectively monitored treatment and post-mortem toxicology of individuals who committed suicide. METHOD: A case-control study of prospectively monitored pharmacological treatment in suicides and controls. Psychiatric records and post-mortem toxicology were also studied. RESULTS: Fifty-nine subjects who committed suicide purchased twice the number of prescriptions as the 118 controls. Sixteen cases received psychiatric in-patient care compared to four of the controls. In the last 3 months prior to suicide, 38 cases (64%) were dispensed drugs: anxiolytics-hypnotics in 17 cases (29%), antipsychotics in six cases (10%) and antidepressants in seven cases (12%). More psychiatrists than GPs prescribed antidepressants. About one-third of psychotropic drugs were retrieved in post-mortem toxicology. CONCLUSION: There is a frequent use of psychotropics and psychiatric care among suicides; however, few used antidepressants and complied. Many suicides are still misdiagnosed and are not adequately treated.

Language: en